Why These 15 Healthcare Stocks Are Surging in 2025

Page 12 of 14

3. Regencell Bioscience Holdings Ltd (NASDAQ:RGC)

Number of Hedge Fund Holders In Q4 2024: N/A

Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is an early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine formulas for neurocognitive disorders like ADHD and autism spectrum disorder, as well as infectious diseases affecting the immune system.

The stock has surged dramatically in 2025, with the most significant catalyst being the announcement of promising clinical trial results for its herbal formula targeting ADHD and ASD in Malaysia. However, this is from an unreliable source. It is more likely that the surge is due to technical reasons.

RGC stock is up 487.25% year-to-date.

Page 12 of 14